Boltz partners with Bristol Myers Squibb to bring its models into drug discovery at GTC
GabriCorso · x · 2026-10-21
Announced at GTC: the Boltz team is partnering with pharma giant Bristol Myers Squibb to integrate the latest Boltz protein structure models into BMS's drug discovery workflows. The team frames it as a major industry milestone, with supporters calling Boltz "on fire" lately.
More from Companies & People
- Follow-up: Google UK's non-disparagement clause lacks protected-disclosure exemptions — BlackHC · 2026-10-22
- SF founder dinners reveal: even 9-figure founders feel the same AI FOMO — dunkhippo33 · 2026-10-22
- Pichai on Gemini 4 Argon: even Google can't get enough AI compute — sundarpichai · 2026-10-22
- Seed founders claiming no salary while living expenses go on the company card — Pavel_Asparagus · 2026-10-22
- Pangram's critics keep getting contradicted so easily that every attack becomes viral marketing — lxrjl · 2026-10-22
- a16z-backed Cosign Awards 2026 opens public nominations across 41 categories — a16z · 2026-10-22